Top compounds associated with response to SREK1


Feature Type Standardized
Nominal ANOVA
mRNA ZG-10 GDSC1000 pan-cancer AAC 0.11 0.02
mRNA QL-X-138 GDSC1000 pan-cancer AAC 0.074 0.02
mRNA PX-12 CTRPv2 pan-cancer AAC 0.065 0.02
mRNA BHG712 GDSC1000 pan-cancer AAC 0.069 0.02
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.03
mRNA ABT-888 CTRPv2 pan-cancer AAC 0.081 0.03
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.03
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.12 0.03
mRNA WH-4-023 GDSC1000 pan-cancer AAC 0.12 0.03
mRNA Tipifarnib GDSC1000 pan-cancer AAC 0.081 0.03
Download CSV